Epsilon M&A Deal Report - Arterin
Transaction Multiples for the Valuation of Private Companies
Omega Pharma / Arterin
No EMAT :
75812
Announced Date :
28/02/2013
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Omega Pharma
Target :
Arterin
Country :
Belgium
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
Business Description :
Launched in 2006 in Belgium and 2008 in France, Arterin business is a cholesterol-related food supplement sold in pharmacies without a medical prescription (OTC). > Arterin contains red yeast rice...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|||||||
| Current |
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 129
| Date | Acquirer | Target | Country | Multiples | See details |
| 18/11/2015 | Charles River Laboratories International | Oncotest | Germany | *** | 75789 |
| 03/06/2015 | Maesa | P2 Cosmetics | Austria | * | 75669 |
Source: Epsilon Research / EMAT
